PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Atrial conduction”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 937 records · Page 52Linked to original sources

Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.

BACKGROUND: Moricizine is said to have potent effects on cardiac conduction but little or no effect on cardiac refractoriness. METHODS AND RESULTS: The effects of moricizine (2 mg/kg IV) on induced atrial flutter were studied 2 to 4 days after the creation of sterile pericarditis in 11 dogs. Ten episodes of stable atrial flutter before and after the administration of moricizine were studied in 9 dogs in the conscious, nonsedated state, and 7 episodes were studied in 6 dogs in the anesthetized, open chest state. In the conscious state, the effects of moricizine on atrial excitability, atrial effective refractory period, and intra-atrial conduction times were studied by recording during overdrive pacing of sinus rhythm from epicardial electrodes placed at selected atrial sites. Moricizine prolonged the atrial flutter cycle length in all the episodes, from a mean of 133 +/- 9 to 172 +/- 27 milliseconds (P < .001), and then terminated 7 of the 10 episodes. Moricizine increased the atrial threshold of excitability from a mean of 2.3 +/- 1.4 to 3.3 +/- 2.2 mA (P < .01) and prolonged intra-atrial conduction times (measured from the sulcus terminalis to the posteroinferior left atrium) from a mean of 58 +/- 6 to 64 +/- 5 milliseconds (P < .005). Prolongation of the atrial effective refractory period from 166 +/- 20 to 174 +/- 24 milliseconds (P < .05) was observed only at the sulcus terminalis site. In the open chest studies, administration of moricizine prolonged the atrial flutter cycle length from a mean of 150 +/- 15 to 216 +/- 30 milliseconds (P < .001) and then terminated the atrial flutter in all 7 episodes. As demonstrated by simultaneous multisite mapping from 95 bipolar sites on the right atrial free wall, the atrial flutter cycle length prolongation was either due to further slowing of conduction in an area of slow conduction in the reentrant circuit of the atrial flutter (5 episodes) or further slowing of conduction in an area of slow conduction plus the development of a second area of slow conduction (2 episodes). The change in conduction times in the rest of the reentrant circuit was negligible (10.9 +/- 8.7% of the total change). In all 7 episodes, the last circulating reentrant wave front blocked in an area of slow conduction. CONCLUSIONS: Moricizine (1) prolongs the atrial flutter cycle length, primarily by slowing conduction in an area of slow conduction in the reentrant circuit, (2) terminates atrial flutter by causing block of the circulating reentrant wave front in an area of slow conduction of the reentrant circuit, and (3) effectively interrupts otherwise stable atrial flutter in this canine model. The reason for these effects of moricizine are not readily explained by its effects on global atrial conduction times and refractoriness studied during sinus rhythm. Local changes in conduction in an area(s) of slow conduction are responsible for both cycle length prolongation and atrial flutter termination rather than the traditional wavelength concept of head-tail interaction.

Animals↗

Unidirectional complete heart block.

Forty-two patients with complete heart block were subjected to electrophysiological studies wherein apart from localization of the site of the conduction defect, ventricular pacing was done to assess ventriculo-atrial (VA) conduction and concealed ventriculo-nodal (VN) conduction. There was evidence of retrograde conduction in the presence of orthograde CHB in 22 patients (52.4 per cent). Fifteen patients (35.7 per cent) had VA conduction and seven (16.6 per cent) had concealed VN conduction. In patients with supra-Hisian CHB, three of the nine patients had VA conduction while of the 11 patients with intra-Hisian CHB, six had retrograde conduction (four with VA and two with concealed VN conduction). In the infra-Hisian CHB group, of the 22 patients, eight had VA conduction and five had concealed conduction. Incremental ventricular pacing induced VA Wenckebach periods at VPR from 110 to 133/minute with a VA interval of 110 to 130 msec. In view of the induction of Wenckebach VA periods, the recording of retrograde H potentials in some cases, and relatively long VA conduction time, it is surmised that retrograde conduction in the presence of orthograde CHB takes place through the AV conduction system.

Adult↗

Predictors of early and late recurrence of atrioventricular accessory pathway conduction after apparently successful radiofrequency catheter ablation.

The correlation between electrophysiologic parameters and recurrence in 239 patients who underwent successful catheter ablation for an accessory pathway mediated tachycardia was analysed. Pathway conduction recurred in 15 patients (6.3%) after a mean follow-up of 7.3 months. Recurrence was most common in patients with right free wall pathways (17.1%). Accessory pathway conduction resumed in 18.9% of patients with decremental ventriculo-atrial (VA) conduction post-ablation compared with those patients without VA conduction (3.4%) (P < 0.001). Recurrence was common also in patients with repeated return of accessory pathway conduction during the ablation procedure (40% vs. 1.3%, P < 0.01). The patients in whom these observations are made should be monitored closely for recurrence of accessory pathway conduction post-ablation.

Adult↗

The differential diagnosis of bigeminal rhythms.

Bigeminal rhythms may arise from ectopic firing or from failure of impulse generation or conduction. In atrial bigeminy a premature atrial beat beat follows each sinus beat. If the PAC is not conducted bradycardia may result; if it is symptomatic treatment with digitalis or quinidine is indicated. Junctional bigeminy may be coupled to sinus beats or may accompany atrial fibrillation. Ventricular bigeminy, the most common type of bigeminy involving ectopic firing, usually requires treatment with suppressive drugs. Concealed bigeminy manifested as PVCs separated by an odd number of sinus beats has the same clinical implications as ventricular bigeminy. Re-entrant premature beats may also be triggered by an artificial ventricular pacemaker. Bigeminy associated with delayed impulse conduction is most often caused by a 3:2 Wenckebach block at the A-V junction but the block may also be at the S-A node or around an ectopic pacemaker. Conduction or production delay may produce "escape-capture" bigeminy in which successive beats are produced by the dominant pacemaker and an alternate one. Implantation of an artificial pacemaker may be appropriate. It is important for the observer to be able to identify the mechanism of any bigeminal rhythm since crucial clinical decisions may attend such identification.

Arrhythmias, Cardiac↗

Atrial pacing during radiofrequency ablation of junctional ectopic tachycardia--a useful technique for avoiding atrioventricular bloc.

Radiofrequency catheter ablation (RFCA) was performed on a 5-year-old boy with congenital junctional ectopic tachycardia (JET) that was refractory to medical management. Because of the lack of retrograde atrial depolarization during tachycardia, radiofrequency energy was delivered during atrial overdrive pacing to confirm the presence of preserved atrioventricular (AV) conduction. Although the procedure was complicated by complete right bundle branch block after ablation of the para-Hissian region, the patient regained sinus rhythm accompanied by normal AV conduction. Rapid atrial pacing during RFCA of JET may be safely used to avoid AV block.

Cardiac Pacing, Artificial↗

Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation.

1. Animal studies suggest that the heart-rate-lowering effect of vagal stimulation during atrial fibrillation is due to: (1) a direct depressant effect on atrioventricular node conductivity, (2) enhancement of concealed atrioventricular nodal conduction of atrial impulses through augmenting fibrillatory activity, thereby indirectly prolonging atrioventricular nodal refractoriness. The purpose of the present study was to analyse these effects in man. 2. Sixteen patients with chronic atrial fibrillation were studied. After administration of propranolol (0.2 mg/kg intravenously) baseline ventricular rhythm was recorded (500 R-R intervals). Recordings were repeated after methylatropine (0.02 mg/kg intravenously). The shortest R-R interval was taken to represent atrioventricular nodal refractoriness. The ratio of the longest to the shortest R-R interval and the coefficient of variation of R-R intervals were used as parameters of concealed conduction. 3. Methylatropine foremost shortened long R-R intervals: values for the mean, shortest and longest R-R intervals decreased from 834 to 685 ms (-18%) (P < 0.001), 573 to 498 ms (-13%) (P < 0.001) and 1228 to 924 ms (-25%) (P < 0.001), respectively. Accordingly, the ratio of the longest to the shortest R-R interval decreased: 2.12 to 1.89 (-11%) (P < 0.05). Also, the coefficient of variation decreased: 0.24 to 0.20 (-17%) (P < 0.05). 4. This study supports the contention that vagal stimulation lowers ventricular rate during atrial fibrillation both by exerting a direct effect on the atrioventricular node and by augmenting concealed conduction.

Adult↗

Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient.

Atrial septal defect (ASD) is the most common form of congenital cardiac defect in humans. Recently, point mutations in the cardiac homeobox gene CSX/NKX2-5 have been reported to cause the autosomal dominant form of familial ASD. Notably, all the affected patients exhibit atrioventricular conduction disturbance and some of them died suddenly. The first case of familial ASD with a mutation of the CSX/NKX2-5 gene in a Japanese patient is reported here. Identification of CSX/NKX2-5 mutations in ASD patients would be very important because the existence of such mutations may predict sudden cardiac death.

Heart Block↗

[The short PR syndrome: sino-atrial block with preservation of sino-nodal conduction].

From among the theories which have been advanced to explain the finding on ECG of a shorter than normal PR interval, in addition to the short circuit theory we should mention the explanation given by Condorelli before the first publication on the "short PR-normal QRS" syndrome appeared. While studying the mechanism of conduction of a stimulus in the atrial myocardium, he showed that a short PR may result from a conduction defect in the sino-atrial pathways, while sino-nodal conduction remains normal. In this report there is an example which supports the validity of Condorelli's hypothesis. It involves a female patient with mitral valve disease beginning to affect the tricuspid. Her rheumatic disease had just relapsed, and after this there was a long period of attacks of tachycardia with arrhythmia during the course of which the surface electrocardiogram showed a short PR and normal QRS. Electrophysiological investigations allowed us to interpret these findings in the light of Condorelli's hypothesis (sino-atrial block with normal sino-nodal conduction). This study suggests that it is useful to separate off those cases with a short PR and normal QRS to a clinical entity of their own, as this syndrome may have a different pathogenesis. Therefore, if there is no electrocardiographic evidence of an accessory pathway, far from indicating accelerated conduction, the short PR may be due to an isolated defect of conduction in the atrial myocardium, as Condorelli suggested. It is also correct that this author should be given credit for describing the first cases. To him also should go credit for first describing the short PR.

Adult↗

Ectopic ventricular tachycardia in association with a concealed accessory pathway.

Ventricular tachycardia may result in retrograde atrial depolarization. In all previous examples studied by intracardiac recording techniques retrograde conduction to the atria has been thought to occur via the normal conduction system. In the patient reported here, 1 : 1 retrograde conduction with atrial preexcitation during ventricular tachycardia indicated the presence of a concealed accessory pathway. This was confirmed by the phenomenon of exact atrial capture. The achievement of atrioventricular dissociation during tachycardia by atrial overdrive pacing excluded a reentrant tachycardia involving such a pathway. The widely variable H--V interval in the presence of a constant V--A interval during tachycardia suggested anterograde His bundle depolarization following atrial activation over the accessory pathway. This hypothesis was supported by the long V--H interval during tachycardia and the relationship of the ventricular, atrial and His bundle electrograms of the first and least beat of the tachycardia. This report illustrates the value of careful electrophysiological investigation in evaluating the relationship of an accessory pathway to the tachycardia mechanism.

Electrophysiology↗

Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.

We observed a dangerous increase of ventricular rate following the intravenous administration of amiodarone in a patient with atrial fibrillation and rapid ventricular response associated with the Wolff-Parkinson-White syndrome. The mechanism of enhanced accessory pathway conduction remains speculative. A possible explanation for the shortened antegrade effective refractory period of the accessory pathway is afforded by the hypotensive action of amiodarone or its dissolvent which might trigger beta-adrenergic reflexes. Intravenous amiodarone should be used with caution in patients with atrial fibrillation and rapid ventricular response via an accessory pathway.

Amiodarone↗

Atrial flutter with 1:1 atrioventricular conduction caused by propafenone.

We describe a case of 1:1 atrial flutter in a patient with coronary disease taking propafenone. In atrial flutter, the atrial rate is usually about 300 beats/min with 2:1 AV conduction and a ventricular rate of 150 beats/min. Class IA antiarrhythmic drugs, especially quinidine and disopyramide, may cause 1:1 AV response because they reduce atrial rate and are vagolytic. However, propafenone is a Class IC agent and has no anticholinergic properties, and the occurrence of 1:1 AV conduction at a rate of about 250 beats/min is an important side effect that, although uncommon, should be recognized.

Anti-Arrhythmia Agents↗